Weight Loss Telehealth in Maryland 12 Providers Compared for 2026

Of the 15 weight loss telehealth platforms we track nationally, 12 are fully available to Maryland residents right now. That means you have real options across budget tiers, medication types, and care styles. Three platforms do not operate here at all: Clinic Secret, Nurx, and UrWay Health. If you have seen those names elsewhere, skip them. They will not serve a Maryland address.

The 12 platforms that do serve Maryland are: Ro, Medvi, MyStart Health, Sprout Health, Skinny.Rx, Hers, Hims, Shed, PlushCare, Sesame Care, Henry Meds, and Peter MD. Strut, Eden, and Ivim Health are also available, though those three lean more heavily toward men's health and hormone optimization rather than weight loss specifically. If weight loss is your primary goal, the 12 named above are where most Maryland residents should focus their time.

Maryland's regulatory environment is reasonably permissive for telehealth prescribing in 2026. Compounded GLP-1 medications like semaglutide and tirzepatide are available through licensed 503B outsourcing pharmacies, which matters because brand-name supply of Wegovy and Zepbound is still inconsistent in parts of the state. Phentermine is legal to prescribe via telehealth in Maryland, unlike some other states where controlled substance restrictions block that option entirely. The standard clinical threshold you will encounter regardless of platform is a BMI of 30 or higher without a comorbidity, or 27 or higher if you have something like hypertension, type 2 diabetes, or sleep apnea.

If you want the lowest monthly cost available to Maryland residents, Medvi is the answer. Their all-inclusive compounded semaglutide pricing runs $149 to $199 per month depending on dose, and that figure covers the medication, provider consultation, and ongoing follow-up. There are no separate pharmacy charges or hidden fees. Medvi earned an 8.9 out of 10 from more than 33,200 verified reviews and carries our top choice designation specifically because the value-to-quality ratio is hard to beat at that price point.

If you have commercial insurance and want someone to fight for brand-name coverage, Ro is built for that fight. Ro has real infrastructure for insurance navigation around Wegovy and Ozempic, which is not something every platform bothers with. Their rating sits at 8.9 from over 32,100 reviews, and they are marked as the most popular platform for a reason. Maryland's full telehealth parity law means your insurer has to reimburse telehealth visits at the same rate as in-person visits, so a Ro consultation is not automatically a cash-out-of-pocket expense if you have coverage.

If you are brand new to weight loss medication and feel overwhelmed, MyStart Health is rated best for beginners and comes with built-in lifestyle coaching alongside the GLP-1 prescription. They offer all-inclusive monthly pricing and have an 8.6 from more than 21,600 reviews. The coaching component is meaningful if you want more hand-holding than a simple prescription renewal service provides. For Maryland residents who want nutritionist support layered in, Sprout Health is another solid option with an 8.5 rating and personalized care plans included in their pricing.

Maryland has full telehealth parity, meaning state law requires commercial insurers to reimburse telehealth visits at the same rate they would pay for the same service delivered in person. This is not universal across all states, and it genuinely changes the math for Maryland residents who have employer-sponsored insurance or a plan purchased through the Maryland Health Benefit Exchange. If your plan covers a weight loss consultation with a physician, that coverage applies whether the appointment is in your living room or a doctor's office.

The catch, and it is an important one, is that parity applies to the visit itself, not necessarily the medication. Wegovy and Zepbound face inconsistent formulary coverage depending on your specific plan. Maryland Medicaid does cover telehealth for weight management visits, but GLP-1 medications through Medicaid are a different story. Coverage depends heavily on your specific Medicaid managed care organization and whether you have a qualifying diagnosis like type 2 diabetes. Ozempic has a stronger Medicaid coverage track record than Wegovy because its primary indication is diabetes, not weight loss.

If you are uninsured or your insurance will not cover GLP-1 medications, the cash-pay market in Maryland is actually competitive. Medvi at $149/month, Skinny.Rx with straightforward monthly compounded semaglutide pricing, and Shed with compounded GLP-1 and behavioral coaching are all built for cash-pay access. PlushCare takes insurance and can see Maryland residents for primary care-based weight management, which is worth considering if you want a platform that might actually bill your insurer successfully rather than defaulting to self-pay.

Maryland residents have access to the full medication menu in 2026: compounded semaglutide, brand-name Wegovy, compounded tirzepatide, brand-name Zepbound, liraglutide, phentermine, metformin, and bupropion-naltrexone. That is not true in every state, so the range here is worth knowing about explicitly.

Compounded semaglutide is the medication most Maryland residents end up on when they go the telehealth route without insurance coverage. It is chemically identical to the active ingredient in Wegovy and Ozempic but produced by a 503B-licensed outsourcing pharmacy rather than Novo Nordisk. The FDA permits this when there is a documented shortage of the brand-name product, which has been the case for Wegovy for much of the past two years. Medvi, Sprout Health, Skinny.Rx, Shed, and MyStart Health all dispense compounded semaglutide to Maryland addresses.

Compounded tirzepatide, the active ingredient in Zepbound and Mounjaro, is also available in Maryland through several platforms. Tirzepatide targets both GIP and GLP-1 receptors, which produces somewhat stronger average weight loss results in clinical trials than semaglutide alone. It is also slightly pricier in compounded form. If affordability is the top concern, semaglutide is still the starting point for most Maryland residents. If you want tirzepatide and do not have insurance coverage for Zepbound, ask your chosen platform explicitly whether they compound tirzepatide, because not every one of the 12 Maryland platforms does.

Brand-name Wegovy and Ozempic are available in Maryland through platforms like Ro and Henry Meds, which have the insurance navigation infrastructure to make pursuing coverage worthwhile. Henry Meds works directly with insurers for GLP-1s and specializes in the diabetes and metabolic health overlap, which is relevant given that Maryland's obesity rate sits at 32.7 percent and many residents seeking weight loss treatment also have a diabetes-adjacent diagnosis that could open insurance doors.

Yes. Phentermine is a controlled substance, and some states have restricted telehealth prescribing of Schedule IV medications to the point where it is effectively unavailable without an in-person visit. Maryland is not one of those states. Telehealth providers operating in Maryland can legally prescribe phentermine after a virtual consultation, provided they establish a valid patient-provider relationship and the clinical picture supports it.

Phentermine works differently from GLP-1 medications. It is a stimulant-adjacent appetite suppressant that has been FDA-approved for short-term weight loss for decades. It is significantly cheaper than semaglutide or tirzepatide, often under $30 per month at a pharmacy with a GoodRx coupon. The tradeoff is that it is typically prescribed for 12 weeks at a time, it carries cardiovascular contraindications, and it does not produce the sustained hormonal signaling effects that GLP-1s do. Platforms like Peter MD and PlushCare, which take a more physician-led primary care approach, are reasonable places to discuss whether phentermine fits your situation. If a platform pushes back and asks for an in-person visit before prescribing phentermine, that is not an obstacle specific to Maryland, it is standard clinical caution for a Schedule IV drug.

Here is the honest pricing picture for Maryland in 2026. Medvi is the floor at $149 to $199 per month for compounded semaglutide, all-inclusive. Skinny.Rx is similarly positioned as a budget option with straightforward monthly pricing for compounded semaglutide, though with fewer reviews (4,378) than most other platforms, so factor that in. Shed offers compounded GLP-1 access with behavioral coaching layered in, and their pricing is competitive for what you get, especially if the accountability component helps you stay consistent.

Sprout Health and MyStart Health sit in a mid-range tier. You are paying somewhat more than Medvi but getting either nutritionist support (Sprout) or lifestyle coaching with beginner-friendly onboarding (MyStart). Both are in the $200 to $300 per month range for most Maryland residents, though your exact cost depends on dose and whether any consultation fees are billed separately. Always confirm what is included before you enter a payment method.

Ro's pricing depends heavily on whether you are pursuing brand-name GLP-1s through insurance or paying out of pocket. If Wegovy is covered by your insurance, your cost through Ro drops to whatever your plan's specialty drug copay is. Without insurance, brand-name Wegovy runs over $1,000 per month at retail. Ro's value proposition is in the insurance navigation, not the cash-pay price. PlushCare and Sesame Care are different models entirely. PlushCare takes insurance and bills it for visits. Sesame Care uses transparent per-visit pricing with no subscription, which is appealing if you want a one-time consult rather than a monthly commitment. Sesame's model works well for Maryland residents who just want a weight loss prescription from a real doctor without signing up for a recurring program.

Henry Meds works directly with insurance for Ozempic and other GLP-1s, which is meaningful if you have a type 2 diabetes diagnosis alongside your weight loss goal. Their 8.6 rating from 12,600 reviews reflects a more specialized focus. If your situation is primarily metabolic or diabetes-adjacent, Henry Meds deserves a serious look over the pure-play weight loss platforms.

Maryland's obesity rate of 32.7 percent is not just a statistic. It means that for a large portion of the state's population, weight is a clinical risk factor connected to cardiovascular disease, type 2 diabetes, hypertension, sleep apnea, and other conditions that insurance companies and physicians treat as serious medical problems. This matters practically because the clinical threshold for GLP-1 prescribing, a BMI of 27 with a comorbidity or 30 without, is met by a substantial portion of Maryland adults who may not realize they qualify.

If you have hypertension, which is extremely common in Maryland's population given the demographics of cities like Baltimore, that alone paired with a BMI of 27 or higher qualifies you for GLP-1 treatment under standard clinical criteria. The same applies to prediabetes, sleep apnea, high cholesterol, or joint problems related to weight. Mentioning these conditions during your telehealth intake is not gaming the system, it is giving your provider the clinical context they need to prescribe appropriately. Every legitimate platform in Maryland will ask about comorbidities during intake specifically because they affect both eligibility and medication choice.

Maryland also has meaningful health disparities across its counties and communities. Baltimore City's obesity rates are higher than suburban Maryland counties, and access to in-person weight loss specialists is geographically uneven. Telehealth specifically solves that access gap. A resident in a rural part of Western Maryland or on the Eastern Shore faces the same online platform options as someone in Montgomery County, which is one of the more practical arguments for using these services rather than searching for an in-person obesity medicine specialist.

Ratings matter when you are choosing a healthcare platform because they reflect real patient experiences at scale. Among the 12 weight loss-relevant platforms serving Maryland, Hims and Strut both sit at 9.0, though Strut is primarily a hair loss and men's health pharmacy rather than a weight loss platform. Medvi and Ro both carry 8.9 ratings with review counts over 32,000, which gives those scores statistical credibility. Hers comes in at 8.8 with nearly 30,000 reviews and is the right women's-health-focused platform if you want weight loss addressed alongside other conditions like hormonal health or mental wellness. Shed and Sesame Care both sit at 8.7.

Eden and Peter MD are available in Maryland but are optimized for men's health rather than weight loss primarily. If you are a Maryland man dealing with ED or testosterone concerns alongside weight gain, they become more relevant. Peter MD specifically covers TRT, ED, weight loss, and hair loss under one physician-led protocol, which can simplify things if you are managing multiple conditions. Ivim Health, rated 8.0, focuses on TRT and metabolic health and may appeal if testosterone optimization is the underlying goal rather than weight loss through GLP-1 medication.

For women in Maryland, Hers is the clearest platform if you want a single place to address weight loss alongside birth control, mental health, or hair concerns. The 8.8 rating from nearly 30,000 reviews is solid, and Hers has improved its GLP-1 offering meaningfully over the past year. That said, if weight loss is your sole focus and cost is a priority, Medvi or Sprout Health will likely serve you better than a general women's wellness platform.

Before you open any platform's intake form, know your BMI and have a rough sense of any health conditions you have been diagnosed with. Your BMI is your weight in kilograms divided by your height in meters squared, but every platform will calculate it for you if you enter your height and weight. The reason to know it in advance is that it determines which medications you qualify for and which platforms will actually move forward with a prescription. Showing up to an intake with a BMI under 27 and no comorbidities means most platforms will not prescribe GLP-1s, regardless of how the marketing made it sound.

If you have insurance and want to pursue coverage, start with Ro or Henry Meds. Both are equipped for the insurance navigation process and can tell you relatively quickly whether your plan is likely to cover Wegovy or Ozempic. If you are self-paying, Medvi is the fastest path to compounded semaglutide at the lowest Maryland-available price. If you want more support built in, MyStart Health or Sprout Health add coaching and nutritionist access for a moderate price increase. If you want zero subscription and just a consult, Sesame Care's per-visit transparent pricing is designed for exactly that.

One thing Maryland residents sometimes overlook: the telehealth parity law means that if you have commercial insurance, asking your platform whether they bill insurance is worth doing before you assume you are paying cash. PlushCare explicitly takes insurance for primary care visits and weight management consultations. Even platforms that default to cash-pay may be able to provide a superbill you can submit to your insurer for reimbursement. It takes an extra step, but given Maryland's parity protections, it is a step that can result in real money back.